EGFR Testing Practices, Treatment Choice and Clinical Outcomes in Advanced NSCLC in a Real-World Setting

被引：0
作者：
Subramanian, J. [1 ]
Gregg, J. [2 ]
Berktas, M. [3 ]
Jiang, Z. [4 ]
Li, J. [4 ]
Taylor, A. [3 ]
Leighl, N. [5 ]
机构：
[1] St Lukes Canc Inst, Kansas City, MO USA
[2] Univ Calif Sacramento, Sacramento, CA USA
[3] AstraZeneca, Oncol Business Unit, Global Real World Evidence Sci, Cambridge, England
[4] AstraZeneca, Gaithersburg, MD USA
[5] Princess Margaret Canc Ctr, Med Oncol, Toronto, ON, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP08.02-08
引用
收藏
页码：S438 / S439
页数：2
相关论文
共 50 条
  • [31] Real-world clinical practice and outcomes in Peruvian patients with advanced EGFR T790M mutation positive NSCLC: A multicenter analysis
    Galvez-Nino, Marco
    Roque, Katia
    Ruiz, Rossana
    Namuche, Fernando
    Paitan, Victor
    Arrese, Tulio
    Zegarra, Jorge
    Oblitas, George
    Gonzalez, Lisde
    Maco, Lorenzo
    Cabrera, Maria del Pilar
    Coello, Roberto
    Pino, Jose Luis Portugal del
    Ezquerra, Juan Carlos
    Roca, Rodolfo Perez
    Coanqui, Ofelia
    Valdiviezo, Natalia
    Olivera, Mivael
    Vidaurre, Tatiana
    Cartagena, Alfredo Aguilar
    Mas, Luis
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2025, 43
  • [32] Real-World Outcomes of Patients with Advanced EGFR-Mutated NSCLC in Canada Using AI-Extracted Data
    Moulson, Ruth
    Law, Jennifer
    Sacher, Adrian
    Liu, Geoffrey
    Shepherd, Frances
    Bradburyb, Penelope
    Eng, Lawson
    Iczkovitz, Sandra
    Abbie, Erica
    Elia-Pacitti, Julia
    Ewara, Emmanuel M.
    Mokriak, Viktoriia
    Weiss, Jessica
    Pettengell, Christopher
    Leighl, Natasha
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E12 - E13
  • [33] Real-World Response and Outcomes in Patients With NSCLC With EGFR Exon 20 Insertion Mutations
    Ou, Sai-Hong Ignatius
    Lin, Huamao M.
    Hong, Jin-Liern
    Yin, Yu
    Jin, Shu
    Lin, Jianchang
    Mehta, Minal
    Nguyen, Danny
    Neal, Joel W.
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (10):
  • [34] Testing patterns and outcomes of different EGFR-positive metastatic non-small cell lung cancer (NSCLC) patients in a Canadian real-world setting
    Boyne, D. J.
    Jarada, T.
    Yusuf, A.
    O'Sullivan, D. E.
    Hu, L. X. Y.
    Brenner, D. R.
    Abbie, E.
    Rose, J. B.
    Eaton, K.
    Ewara, E. M.
    Cheung, W. Y.
    ANNALS OF ONCOLOGY, 2022, 33 : S56 - S56
  • [35] Real-World Treatment Patterns and Outcomes in Patients With Advanced NSCLC Treated After Prior Chemotherapy and Immunotherapy
    Haggstrom, D.
    Mhatre, S. K.
    Chen, F.
    Gao, R.
    Carroll, C.
    Patel, R.
    Park, J.
    Descoteaux, A.
    Stokes, M.
    Daniel, D.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S409 - S409
  • [36] Sequential treatment with afatinib and osimertinib in real-world patients with EGFR mutation-positive advanced NSCLC: the GioTag study
    Hochmair, M.
    Cufer, T.
    Morabito, A.
    Hao, D.
    Yang, C.
    Soo, R.
    Yang, J. C.
    Gucalp, R. Rasim
    Halmos, B.
    Wang, L.
    Golembesky, A.
    Maerten, A.
    O'Byrne, K.
    LUNG CANCER, 2019, 127 : S37 - S37
  • [37] Real-world clinical analysis in 190 advanced NSCLC patients with uncommon EGFR mutations: A multi-center study
    Qin, Yi
    Long, Yaling
    Tang, Yuan
    Tian, Yuke
    Li, Juan
    Duan, Ping
    Luo, Jieyan
    Yu, Min
    Li, Yanying
    Zhou, Xiaojuan
    Wang, Ke
    Gong, Youling
    Peng, Feng
    Zhu, Jiang
    Liu, Yongmei
    Zhou, Lin
    Lu, You
    Huang, Meijuan
    CANCER SCIENCE, 2023, 114 (06) : 2552 - 2559
  • [38] Real World Outcomes of Immunotherapy for Treatment of Advanced Stage NSCLC in Jordan
    Abu Hejleh, T.
    Al Sawalha, K.
    Hafiz, S. Abdel
    Yaser, S.
    Abu Jazar, H.
    Khader, J.
    Alnsour, A.
    Mohamad, I.
    Jalil, R. Abdel
    Abu-Shanab, A.
    Gharaibeh, A.
    Abu Shattal, M.
    Al-Ibraheem, A.
    Haddad, H.
    Mahmoud, N.
    Obeidat, S.
    Al-Rabi, K.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S619 - S619
  • [39] Real-world treatment patterns and clinical outcomes in advanced cutaneous melanoma patients in France
    Sassolas, B.
    Leccia, M. T.
    Godard, C.
    Benmahamed, L.
    Flinois, A.
    Levy-Bachelot, L.
    Bedane, C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (04) : 587 - 594
  • [40] Sequential treatment with afatinib and osimertinib in real-world patients with EGFR mutation-positive advanced NSCLC: the GioTag study
    Hochmair, M.
    Cufer, T.
    Morabito, A.
    Hao, D.
    Yang, C. Ta
    Soo, R.
    Yang, J.
    Gucalp, R.
    Halmos, B.
    Wang, L.
    Golembesky, A.
    Maerten, A.
    O'Byrne, K.
    LUNG CANCER, 2019, 127 : S59 - S60
12345